High-voltage electrical pulses in oncology: irreversible electroporation, electrochemotherapy, gene electrotransfer, electrofusion, and electroimmunotherapy
B Geboers, HJ Scheffer, PM Graybill, AH Ruarus… - Radiology, 2020 - pubs.rsna.org
This review summarizes the use of high-voltage electrical pulses (HVEPs) in clinical
oncology to treat solid tumors with irreversible electroporation (IRE) and …
oncology to treat solid tumors with irreversible electroporation (IRE) and …
Irreversible electroporation: background, theory, and review of recent developments in clinical oncology
KN Aycock, RV Davalos - Bioelectricity, 2019 - liebertpub.com
Irreversible electroporation (IRE) has established a clinical niche as an alternative to thermal
ablation for the eradication of unresectable tumors, particularly those near critical vascular …
ablation for the eradication of unresectable tumors, particularly those near critical vascular …
Percutaneous irreversible electroporation in locally advanced and recurrent pancreatic cancer (PANFIRE-2): a multicenter, prospective, single-arm, phase II study
AH Ruarus, LGPH Vroomen, B Geboers… - Radiology, 2020 - pubs.rsna.org
Background Patients with locally advanced pancreatic cancer have a dismal prognosis, with
a median overall survival (OS) of 12–14 months with systemic therapies. Irreversible …
a median overall survival (OS) of 12–14 months with systemic therapies. Irreversible …
Irreversible electroporation and electrochemotherapy in oncology: State of the art
JP Tasu, D Tougeron, MP Rols - Diagnostic and Interventional Imaging, 2022 - Elsevier
Thermal tumor ablation techniques including radiofrequency, microwave, LASER, high-
intensity focused ultrasound and cryoablation are routinely used to treated liver, kidney …
intensity focused ultrasound and cryoablation are routinely used to treated liver, kidney …
Irreversible electroporation plus allogenic Vγ9Vδ2 T cells enhances antitumor effect for locally advanced pancreatic cancer patients
M Lin, X Zhang, S Liang, H Luo, M Alnaggar… - … and Targeted Therapy, 2020 - nature.com
Immunotherapy has limited efficacy against locally advanced pancreatic cancer (LAPC) due
to the presence of an immunosuppressive microenvironment (ISM). Irreversible …
to the presence of an immunosuppressive microenvironment (ISM). Irreversible …
Irreversible electroporation: an emerging immunomodulatory therapy on solid tumors
N Zhang, Z Li, X Han, Z Zhu, Z Li, Y Zhao… - Frontiers in …, 2022 - frontiersin.org
Irreversible electroporation (IRE), a novel non-thermal ablation technique, is utilized to
ablate unresectable solid tumors and demonstrates favorable safety and efficacy in the …
ablate unresectable solid tumors and demonstrates favorable safety and efficacy in the …
Irreversible electroporation combined with checkpoint blockade and TLR7 stimulation induces antitumor immunity in a murine pancreatic cancer model
JSS Narayanan, P Ray, T Hayashi, TC Whisenant… - Cancer immunology …, 2019 - AACR
Irreversible electroporation (IRE) is a nonthermal ablation technique that is used clinically in
selected patients with locally advanced pancreatic cancer, but most patients develop …
selected patients with locally advanced pancreatic cancer, but most patients develop …
Locally advanced pancreatic cancer: work-up, staging, and local intervention strategies
E van Veldhuisen, C van den Oord, LJ Brada… - Cancers, 2019 - mdpi.com
Locally advanced pancreatic cancer (LAPC) has several definitions but essentially is a
nonmetastasized pancreatic cancer, in which upfront resection is considered not beneficial …
nonmetastasized pancreatic cancer, in which upfront resection is considered not beneficial …
[HTML][HTML] Local ablation of pancreatic tumors: State of the art and future perspectives
Local ablation of pancreatic tumors: State of the art and future perspectives - PMC Back to Top
Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main …
Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main …
Locally advanced pancreatic cancer: a review of local ablative therapies
A Ruarus, L Vroomen, R Puijk, H Scheffer, M Meijerink - Cancers, 2018 - mdpi.com
Pancreatic cancer is typically characterized by its aggressive tumor growth and dismal
prognosis. Approximately 30% of patients with pancreatic cancer present with locally …
prognosis. Approximately 30% of patients with pancreatic cancer present with locally …